C60 - Precision Neurology: The Promise and Perils of Personalized Medicine in the Genomic Era

Event Time: Sunday April 23, 2017 3:30 pm to 5:30 pm
Topic(s): General Neurology, Research Methodology, Education, and History
Director(s): Peter Todd MD, PhD
Description: Addressing the rapidly developing area of Precision Medicine, this two-hour symposium will discuss the potential power and pitfalls of next generation genetic testing for people with and at risk for neurological disorders and how these technologies are already influencing our understanding of neurological disease. The first part of the symposium will address the broad question of what impact next gen sequencing (NGS) has on personalized medicine and genomics in neurological practice, both now and going forward. The second half of the session will address how genetic background influences genetic and sporadic neurological disease and how these background effects are broadening our comprehension of genotype/phenotype relationships.
Completion Message: Participants will be aware of the different types of genetic testing tools available for clinical and research purposes, when to get these tests, and what to do with the information when they have it. They will also gain a greater understanding of how these tools might be used in the future for people with both genetically based neurological disorders and common neurological diseases. They will also learn about how disclosure of genetic results impacts patients and about how somatic mutations and repeat expansion contribute to the burden of neurological disease.
CME Credits: 2
Core Competencies: Medical Knowledge, Patient Care

Ready to register for the 2018 AAN Annual Meeting?

Register Now

Related Courses